Enhabit, Inc. (EHAB) Stock Analysis

Enhabit, Inc. (EHAB) Healthcare & Pipeline Overview

Enhabit, Inc., operating as a standalone entity since 2022, delivers home health and hospice services across 34 states. With a focus on patient education, pain management, and palliative care, Enhabit addresses chronic conditions and end-of-life needs, positioning itself within the growing healthcare services sector.

What Is the Investment Thesis for EHAB?

Enhabit, Inc. presents a focused investment opportunity within the healthcare services sector, specifically in the growing home health and hospice market. The company's standalone operational structure, established in July 2022, allows for strategic focus and resource allocation to enhance its service offerings and expand its market presence. With a gross margin of 36.1%, Enhabit demonstrates potential for profitability improvements through operational efficiencies and strategic cost management. Growth catalysts include expanding its network of home health and hospice agencies and capitalizing on the increasing demand for in-home care services. However, the company's negative profit margin of -0.3% and a market capitalization of $707M indicate ongoing financial challenges that require careful monitoring.

Based on FMP financials and quantitative analysis

EHAB Key Highlights

Operates 252 home health agencies and 99 hospice agencies across 34 states as of March 31, 2022, showcasing a broad geographic footprint.

• Gross margin of 36.1% indicates potential for profitability through efficient cost management.
• Standalone company since July 1, 2022, allowing for focused strategic initiatives and resource allocation.
• Offers a comprehensive suite of home health services, including specialized care for chronic diseases and post-operative rehabilitation.
• Provides hospice services encompassing pain management, counseling, and spiritual support for terminally ill patients and their families.

Who Are EHAB's Competitors?

EHAB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are EHAB's Key Strengths?

Wide geographic presence with operations in 34 states.

• Comprehensive service offerings, including home health and hospice care.
• Experienced management team with expertise in healthcare services.
• Established relationships with healthcare providers and referral sources.

What Are EHAB's Weaknesses?

Negative profit margin indicates financial challenges.

• High operating costs associated with maintaining a large network of agencies.
• Dependence on government reimbursement programs.
• Intense competition in the home health and hospice market.

What Could Drive EHAB Stock Higher?

Expansion of service offerings to include specialized care programs.

• Strategic partnerships with healthcare providers to expand referral network.
• Integration of technology to improve operational efficiency and patient care.
• Potential acquisitions of smaller home health and hospice agencies to expand market presence.

What Are the Key Risks for EHAB?

Negative return on equity (-0.6%) — the business is not currently generating profit on shareholder capital.

• Insider selling — insiders were net sellers of roughly $9.8M recently.
• Changes in government regulations and reimbursement policies.
• Intense competition from other home health and hospice providers.
• Rising labor costs and workforce shortages.
• Litigation and regulatory scrutiny.
• Negative profit margin impacting financial stability.

What Are the Growth Opportunities for EHAB?

• Expansion of Home Health Services: Enhabit can capitalize on the growing demand for home health services by expanding its service offerings and geographic reach. The market for home healthcare is projected to reach $300 billion by 2028, driven by an aging population and increasing preference for in-home care. Enhabit can leverage its existing infrastructure and expertise to penetrate new markets and offer specialized services such as chronic disease management and post-acute care, enhancing its competitive position and revenue streams.
• Strategic Acquisitions: Enhabit can pursue strategic acquisitions of smaller home health and hospice agencies to expand its market presence and service capabilities. The fragmented nature of the industry provides opportunities to consolidate regional players and integrate them into Enhabit's network. By acquiring agencies with complementary service offerings or geographic coverage, Enhabit can enhance its competitive advantage and achieve economies of scale, driving revenue growth and profitability.
• Enhanced Technology Integration: Investing in advanced technology solutions can improve operational efficiency and enhance patient care. Implementing telehealth platforms, remote monitoring devices, and electronic health records can streamline workflows, reduce costs, and improve patient outcomes. By leveraging technology, Enhabit can differentiate itself from competitors and attract patients seeking innovative and convenient healthcare solutions.
• Partnerships with Healthcare Providers: Collaborating with hospitals, physician groups, and other healthcare providers can expand Enhabit's referral network and increase patient volume. By establishing partnerships with key stakeholders in the healthcare ecosystem, Enhabit can gain access to a broader patient base and enhance its reputation as a trusted provider of home health and hospice services. These partnerships can also facilitate the development of integrated care models that improve patient outcomes and reduce healthcare costs.
• Focus on Specialized Care Programs: Developing specialized care programs for specific patient populations, such as those with chronic diseases or post-surgical needs, can differentiate Enhabit from competitors and attract patients seeking specialized expertise. By offering tailored care plans and dedicated support services, Enhabit can improve patient outcomes, enhance patient satisfaction, and increase revenue per patient. These specialized programs can also attract referrals from physicians and other healthcare providers seeking specialized care for their patients.

What Are EHAB's Competitive Advantages?

• Established network of home health and hospice agencies across multiple states.
• Comprehensive range of services, including specialized care for chronic diseases and post-operative rehabilitation.
• Strong relationships with healthcare providers and referral sources.
• Expertise in navigating complex regulatory requirements and reimbursement processes.

What Does EHAB Do?

Enhabit, Inc., established in 2014 and headquartered in Dallas, Texas, emerged as a standalone company on July 1, 2022, after previously operating as Encompass Health Home Health Holdings, Inc. The company specializes in providing home health and hospice services across the United States, operating through 252 home health agencies and 99 hospice agencies as of March 31, 2022, spanning 34 states. Enhabit's home health services encompass a wide range of medical support, including patient education, pain management, wound care, cardiac rehabilitation, infusion therapy, and pharmaceutical administration. They also offer specialized practices for managing chronic diseases such as diabetes, hypertension, arthritis, Alzheimer's disease, and Parkinson's disease. Therapy services, including physical, occupational, and speech therapy, are integral to their home health offerings. Enhabit's hospice services provide comprehensive care for terminally ill patients and their families, focusing on pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement support. The company's mission is to meet the physical, emotional, spiritual, and psychosocial needs of patients and their families during challenging times.

What Products and Services Does EHAB Offer?

• Provides patient education to help individuals understand their health conditions and treatment plans.
• Offers pain management services to alleviate discomfort and improve quality of life.
• Delivers wound care and dressing changes to promote healing and prevent infections.
• Conducts cardiac rehabilitation programs to improve cardiovascular health.
• Administers infusion therapy and pharmaceutical treatments in the comfort of patients' homes.
• Offers skilled observation and assessment services to monitor patients' health status.
• Provides physical, occupational, and speech therapy services to improve mobility, function, and communication skills.
• Offers hospice services, including palliative care, counseling, and spiritual support for terminally ill patients and their families.

How Does EHAB Make Money?

• Generates revenue by providing home health services to patients in their homes.
• Earns income through hospice care services for terminally ill patients and their families.
• Receives payments from Medicare, Medicaid, private insurance companies, and direct patient payments.
• Operates through a network of home health and hospice agencies across multiple states.

What Industry Does EHAB Operate In?

Enhabit, Inc. operates within the medical care facilities industry, which is experiencing growth driven by an aging population and increasing preference for in-home healthcare services. The industry is characterized by a mix of large national providers and smaller regional players. Enhabit's focus on both home health and hospice services positions it to capture a significant share of the market. The competitive landscape includes other major players in the home healthcare and hospice sectors, requiring Enhabit to differentiate itself through service quality, geographic reach, and specialized care offerings.

Who Are EHAB's Key Customers?

• Individuals requiring medical care and support in their homes.
• Terminally ill patients seeking comfort and palliative care.
• Families of patients needing assistance with caregiving and emotional support.
• Healthcare providers referring patients for home health and hospice services.

Company Profile

Enhabit, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Dallas, US. The company is led by CEO Barbara Ann Jacobsmeyer. EHAB has traded publicly since 2022.

Return on equity for Enhabit, Inc. stands at -0.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 11.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.56 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.5%, the inverse of the P/E and a quick read on earnings relative to price.

EHAB Valuation & Market Position

With a $707M market cap, Enhabit, Inc. sits in the small-cap segment of the market. Analyst price targets span from $12.00 to $14.00, with a consensus of $13.53. At the current price of $13.80, that implies roughly 2% downside from the consensus target.

Quarterly Financial Performance: Enhabit, Inc.

Revenue for Enhabit, Inc. came in at $264.8M during Mar 2026, a 2.1% contraction versus the preceding quarter. The company recorded net income of $19.2M, with diluted EPS of $0.36. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, EHAB averaged $-0.02 in diluted EPS.

Enhabit, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.94 places it in the grey zone, a middle ground that warrants monitoring.

Enhabit, Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 9.8% above estimates on average.

Wall Street analysts project Enhabit, Inc. revenue of about $1.10B for fiscal 2026, with EPS near $0.60. The estimate reflects 3 contributing analysts.

Over the past six months, Enhabit, Inc. insiders filed 54 SEC Form 4 transactions — 30 sales and 24 purchases. On net that is roughly 713K shares disposed (about $9.8M), a signal worth weighing alongside the fundamentals.

EHAB Financials

EHAB Latest News

Common Questions About EHAB (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources